PF-03882845

DB11814InvestigationalSmall molecule

PF-03882845 has been used in trials studying the basic science of Diabetes Mellitus, Type 2 and Type 2 Diabetic Nephropathy.

Chemical structure of PF-03882845
Mechanism
Curator reviewed
Formula / weight
C24H22ClN3O2 · 419.91 g/mol (avg)
Code names
PF-3882845

Resolves to

Compound
UNII34ZKU73FU3CAS1023650-66-9ChEMBLCHEMBL1215331PubChem46871935
Structure
InChIKeyXNULRSOGWPFPBL-REWPJTCUSA-NSMILESOC(=O)C1=CC2=C(C=C1)C1=NN([C@@H](C3CCCC3)[C@H]1CC2)C1=CC=C(C#N)C(Cl)=C1
Targets
P08235NR3C2

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
4Clinical trialsPhase, status and sponsor resolved per trial
Sign in
3+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with PF-03882845, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In